David Peters, PhD
Associate Professor, Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh
I am focused on developing blood tests, and other non-invasive methods, for the early detection and analysis of complex human diseases. My goal is to reduce the burden and impact of disease through earlier and more accurate diagnosis that informs personalised approaches to treatment.
David Peters, PhD
Research in Brief
Research at the lab is built around two related themes. The first is the development of non-invasive diagnostic tests for fetal genetic disease. The second is the analysis of epigenetic changes associated with normal development and reproductive disease. To achieve these goals, the lab combines high-throughput methods in genomics with computational methods.
- Katz TA, Liao SG, Palmieri VJ, Dearth RK, Pathiraja TN, Huo Z, Shaw P, Small S, Davidson NE, Peters DG, Tseng GC, Oesterreich S, Lee AV. Targeted DNA methylation screen in the mouse mammary genome revels a parity-induced hypermethlation of IGF1R which persists long after parturition. Cancer Prev Res (Phila). 2015;8(10):1000-9.
- Chu T, Yeniterzi S, Yatsenko SA, Dunkel M, Rajkovic A, Hogge WA, Peters DG*. Cell-free nucleic acids as non-invasive biomarkers of gynecological disorders, fetal aneuploidy and constitutional maternal chromosomal mosaicism. Hum Reprod Update. 2015;21(5):690-2.
- Yatsenko SA, Peters DG, Saller DN, Chu T, Clemens M, Rajkovic A. Maternal cell free DNA based screening for fetal microdeletion and the importance of careful diagnostic follow up. Genet Med. 2015;17(10):836-8.
- Peters DG*, Yatsenko SA, Surti U, Rajkovic A. Recent advances of genomic testing in perinatal medicine. Semin Perinatol. 2015;39(1):44-54.
- Chu TJ, Yeniterzi, Rajkovic A, Hogge WA, Dunkel M, Shaw PA, Bunce K, Peters DG*. High resolution non-invasive detection of a fetal microdeletion using the GCREM algorithm. Prenat Diagn. 2014;34(5):469-77.
For additional publications, visit Pubmed.